Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
New NHS Programme to Find and Cure Hidden Hepatitis C
Thousands more people will get potentially life-saving treatment for Hepatitis C thanks to a new […]
£30m for Scientists to Rewrite DNA to Cure Killer Heart Diseases
An injectable cure for inherited heart muscle conditions that can kill young people in the […]
Novasenta Completes $40 million Series A to Advance Novel Cancer Therapeutics
Novasenta Inc., a startup biotechnology company focused on the discovery and validation of novel targets […]
Vico Therapeutics Appoints Micah Mackison as Chief Executive Officer
Vico Therapeutics B.V., a neurology-focused genetic medicine company, today announced the appointment of Micah Mackison as Chief […]
GSK Signs Agreement to Support Pandemic Preparedness in Europe
GSK plc (LSE/NYSE: GSK) today announced it had signed a framework contract with the European […]
Taiwan Firm AHEAD Medicine Disrupting Cell Analysis With AI to Help Accelerate Disease Diagnostics and Cell Therapy Worldwide
AHEAD Medicine, a UC Berkeley SkyDeck-backed company has launched a new AI-enabled cell immuno-profiling analysis […]
NeuroSense Therapeutics and NeuraLight Collaborate to Detect ALS Oculometric Biomarkers Using AI and ML
NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, and NeuraLight, a company […]
Caption Health and Heartbeat Health Partner to Provide Unprecedented Access to Cardiac Care
Caption Health, the leader in providing services and AI to improve heart ultrasound access, and […]
Pfizer and BioNTech Advance COVID-19 Vaccine Strategy With Study Start of Next-Generation Vaccine Candidate Based on Enhanced Spike Protein Design
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the companies have initiated a randomized, […]
Mymee Acquires Breakthrough Health, Leading Digital Health Platform for Multiple Sclerosis
Mymee, a leading provider of specialized care and support for people with significant symptoms associated […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more